Skip to main content

RHUMBLINE ADVISERS

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in ALLO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$490,505
+$212,387 QoQ
Shares Held
201,027
-1.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 20% Shared 0% None 80%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. ALLO ranks #158 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALLO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $490,505 201,027
2025-12-31 $278,118 203,006
2025-09-30 $261,300 210,726
2025-06-30 $236,549 209,336
2025-03-31 $268,213 183,708
2024-12-31 $408,350 191,714
2024-09-30 $487,723 174,187
2024-06-30 $383,303 164,508
2024-03-31 $679,596 152,035
2023-12-31 $468,534 145,961
2023-09-30 $441,089 139,145
2023-06-30 $716,877 144,241
2023-03-31 $638,406 129,232
2022-12-31 $789,407 125,502
2022-09-30 $1,391,828 128,873
2022-06-30 $1,353,168 118,699
2022-03-31 $769,047 84,418
2021-12-31 $1,341,621 89,921
2021-09-30 $2,332,737 90,768
2021-06-30 $2,290,606 87,830
2021-03-31 $2,166,078 61,362
2020-12-31 $1,701,075 67,396
2020-09-30 $2,419,624 64,164
2020-06-30 $3,253,891 75,990
2020-03-31 $1,061,112 54,584